Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 21, 2022
Patent Application Number
16953304
Date Filed
November 19, 2020
Patent Citations
Patent Primary Examiner
CPC Code
Provided herein are modified anti-SARS-COV-2 antibodies or antigen binding fragments thereof having extended half life and optimized immune activities. Disclosed herein is also directed to pharmaceutical compositions comprising the same and a method for treating or preventing a disease in human patients that is caused by or related to the infection of SARS-COV-2.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
